Balyasny Asset Management
LOXO

Balyasny Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

Balyasny Asset Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-23,500
Closed -$3.66M – 1961
2018
Q3 		$3.66M Buy
+23,500
New +$3.95M 0.02% 806

Other funds holding LOXO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management's LOXO Position: Q4 2018 in Review

Balyasny Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q4 2018, closing a stake of 2,055 shares — an estimated $351K sold.

Balyasny Asset Management first reported a position in LOXO in Q4 2015 and held it in 9 quarters. The position peaked at $32.1M in Q4 2017. 232 funds tracked by Wall St. Rank hold LOXO as of Q4 2018.

  • Balyasny Asset Management reported no remaining Loxo Oncology, Inc position as of Q4 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 2,055 Loxo Oncology, Inc shares in Q4 2018, an estimated $351K.
  • Balyasny Asset Management first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 9 quarters.
  • Balyasny Asset Management's Loxo Oncology, Inc position peaked at $32.1M in Q4 2017.
  • 232 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2018.

Based on Balyasny Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.